LAVAL, Quebec, April 11, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today issued the following statement regarding the Senate Committee on Aging’s subpoena to depose Valeant Chief Executive Officer, J. Michael Pearson:
“The Board has…